Details of the Target
General Information of Target
Probe(s) Labeling This Target
ABPP Probe
| Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
|---|---|---|---|---|---|
|
DBIA Probe Info |
![]() |
C1122(2.41) | LDD2894 | [1] | |
PAL-AfBPP Probe
| Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
|---|---|---|---|---|---|
|
DA-2 Probe Info |
![]() |
N.A. | LDD0070 | [2] | |
Competitor(s) Related to This Target
The Interaction Atlas With This Target
The Protein(s) Related To This Target
Enzyme
The Drug(s) Related To This Target
Approved
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Crizotinib | Small molecular drug | D03ZBT | |||
| Entrectinib | Small molecular drug | D0O0LS | |||
| Fostamatinib | Small molecular drug | DB12010 | |||
| Lorlatinib | . | D0AF6O | |||
Phase 2
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Ab-106 | Small molecular drug | D2KV8B | |||
| Tpx-0005 | . | D05NFR | |||
Phase 1
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Ds-6051 | . | D0N0DU | |||
Investigative
| Drug Name | Drug Type | External ID | |||
|---|---|---|---|---|---|
| Pmid24432909c8e | Small molecular drug | D0K5UF | |||
Patented
References


